Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type (1 selected)

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 1391 to 1400 of 2039

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
TNF-alpha inhibitors for treating active ankylosing spondylitis and non-radiographic axial spondyloarthritisTA383
Percutaneous coblation of the intervertebral disc for low back pain and sciaticaHTG397
Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciaticaHTG398
Percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back painHTG399
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA377
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapyTA378
Nintedanib for treating idiopathic pulmonary fibrosisTA379
Panobinostat for treating multiple myeloma after at least 2 previous treatmentsTA380
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)TA382
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failedTA375

Results per page

  1. 10
  2. 25
  3. 50
  4. All